Business Context and Reporting Period
This Form 8-K Current Report was filed by Applied Materials, Inc. on November 4, 2015. The report addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and associated compensation arrangements.
Material Changes
On November 4, 2015, the Board of Directors appointed Eric Chen as a member of the Board and the Strategy Committee, effective immediately. This appointment introduces a new governance structure member but does not represent a material change to the company's financial operations or business strategy as described in this document.
Guidance, Outlook, and Compensation Details
Management commentary is limited to the terms of Dr. Chen's appointment. The compensation package includes:
- Annual Retainer: $65,000 (prorated based on service during the year).
- Meeting Fees: $2,000 for each committee meeting attended.
- Equity Grant: An automatic grant of restricted stock units (RSUs) valued at $200,000, divided by the market value of common stock on the appointment date. This grant is prorated for the period from appointment until the 2016 Annual Meeting of Stockholders.
- Vesting Schedule: RSUs vest in full on March 1, 2016, contingent upon continued service.
The filing contains no forward-looking guidance, risk factors, or contingencies beyond the standard vesting conditions for the new director.
Investor Verification Checklist
- Verify the exact number of RSUs granted to Dr. Chen based on the stock price on November 4, 2015.
- Confirm Dr. Chen's background and qualifications for the Strategy Committee role.
- Review the total number of directors on the Board following this appointment.
- Check subsequent filings for any changes to the vesting schedule or compensation terms.